• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼眶成纤维细胞对促炎细胞因子呈现出一种新的反应模式:甲状腺相关眼病发病机制的潜在基础。

Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.

作者信息

Smith Terry J

机构信息

Division of Molecular Medicine, Harbor-UCLA Medical Center, Torrance, California 90502-2006, USA.

出版信息

Thyroid. 2002 Mar;12(3):197-203. doi: 10.1089/105072502753600133.

DOI:10.1089/105072502753600133
PMID:11952039
Abstract

Thyroid-associated ophthalmopathy (TAO) represents a process confined to the orbit where the connective tissue becomes inflamed and accumulates the glycosaminoglycan, hyaluronan. Ultimately, the orbital tissues become extensively remodeled. Evidence points to the recruitment and activation of T cells as critical elements initiating and driving the pathogenesis of TAO. The phenotype of orbital fibroblasts appears to be distinct from that of other types of fibroblasts. These cells exhibit particularly robust responses to a number of T-cell-derived cytokines. Notable among these are the inductions of key inflammatory genes and their products. We hypothesize that exaggerated cellular responses represent the basis for the involvement of the orbit in Graves' disease.

摘要

甲状腺相关眼病(TAO)是一种局限于眼眶的病变,其中结缔组织发生炎症并积聚糖胺聚糖——透明质酸。最终,眼眶组织会发生广泛重塑。有证据表明,T细胞的募集和激活是引发和推动TAO发病机制的关键因素。眼眶成纤维细胞的表型似乎与其他类型的成纤维细胞不同。这些细胞对多种T细胞衍生的细胞因子表现出特别强烈的反应。其中值得注意的是关键炎症基因及其产物的诱导。我们推测,过度的细胞反应是眼眶参与格雷夫斯病的基础。

相似文献

1
Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.眼眶成纤维细胞对促炎细胞因子呈现出一种新的反应模式:甲状腺相关眼病发病机制的潜在基础。
Thyroid. 2002 Mar;12(3):197-203. doi: 10.1089/105072502753600133.
2
The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy.
Exp Clin Endocrinol Diabetes. 1999;107 Suppl 5:S160-3. doi: 10.1055/s-0029-1212175.
3
Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor.格雷夫斯病患者的免疫球蛋白通过自身抗原胰岛素样生长因子-I受体诱导其眼眶成纤维细胞合成透明质酸。
J Clin Endocrinol Metab. 2004 Oct;89(10):5076-80. doi: 10.1210/jc.2004-0716.
4
[Interactions of fibroblasts, adipocytes and immunocompeent cells in the pathogenesis of endocrine ophthalmopathy].[成纤维细胞、脂肪细胞与免疫活性细胞在内分泌性眼病发病机制中的相互作用]
Acta Med Austriaca. 2001;28(4):89-92. doi: 10.1046/j.1563-2571.2001.01021.x.
5
Unique properties of orbital connective tissue underlie its involvement in Graves' disease.眼眶结缔组织的独特特性是其参与格雷夫斯病的基础。
Minerva Endocrinol. 2003 Sep;28(3):213-22.
6
Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.CD34+ 纤维细胞伪装成眼眶成纤维细胞在甲状腺相关眼病中的潜在作用。
J Clin Endocrinol Metab. 2019 Feb 1;104(2):581-594. doi: 10.1210/jc.2018-01493.
7
Pathogenesis of ophthalmopathy in autoimmune thyroid disease.自身免疫性甲状腺疾病中眼病的发病机制。
Rev Endocr Metab Disord. 2000 Jan;1(1-2):87-95. doi: 10.1023/a:1010020621687.
8
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.格雷夫斯病和眼病发病机制的当前观点。
Endocr Rev. 2003 Dec;24(6):802-35. doi: 10.1210/er.2002-0020.
9
Autoantibodies to eye muscle and orbital fibroblasts in the pathogenesis of thyroid-associated ophthalmopathy.甲状腺相关性眼病发病机制中针对眼肌和眼眶成纤维细胞的自身抗体。
Exp Clin Endocrinol. 1991 May;97(2-3):197-201. doi: 10.1055/s-0029-1211064.
10
Thyroid-associated eye disease.甲状腺相关性眼病
Strabismus. 2000 Jun;8(2):101-11.

引用本文的文献

1
Biomechanical changes of the cornea after orbital decompression in thyroid-associated orbitopathy measured by corvis ST.应用 Corvis ST 测量甲状腺相关眼病眼眶减压术后角膜的生物力学变化。
Sci Rep. 2024 Jul 23;14(1):16930. doi: 10.1038/s41598-024-68081-8.
2
PAPP-A as a Potential Target in Thyroid Eye Disease.PAPP-A 作为甲状腺眼病的潜在靶点。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3119-3125. doi: 10.1210/clinem/dgae339.
3
RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
RNA 适体与 CD40(CD40Apt)具有特异性结合亲和力,代表了一种有前途的 CD40-CD40L 信号通路拮抗剂,可用于治疗甲状腺相关眼病(TAO)的小鼠模型。
J Transl Med. 2023 Jun 18;21(1):396. doi: 10.1186/s12967-023-04217-0.
4
Integrative metabolic analysis of orbital adipose/connective tissue in patients with thyroid-associated ophthalmopathy.甲状腺相关眼病患者眶脂肪/结缔组织的综合代谢分析。
Front Endocrinol (Lausanne). 2022 Nov 18;13:1001349. doi: 10.3389/fendo.2022.1001349. eCollection 2022.
5
Therapeutic Effect of α-MSH in Primary Cultured Orbital Fibroblasts Obtained from Patients with Thyroid Eye Disease.α-MSH 在甲状腺眼病患者原代培养眼眶成纤维细胞中的治疗作用。
Int J Mol Sci. 2021 Oct 18;22(20):11225. doi: 10.3390/ijms222011225.
6
2021 update on thyroid-associated ophthalmopathy.2021 年甲状腺相关眼病更新。
J Endocrinol Invest. 2022 Feb;45(2):235-259. doi: 10.1007/s40618-021-01663-9. Epub 2021 Aug 20.
7
Updates on the understanding and management of thyroid eye disease.甲状腺眼病的认识与管理进展
Ther Adv Ophthalmol. 2021 Jun 30;13:25158414211027760. doi: 10.1177/25158414211027760. eCollection 2021 Jan-Dec.
8
Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy.甲状腺相关眼病:特普西单抗作为一种有前途的医学治疗方法的出现。
Best Pract Res Clin Endocrinol Metab. 2020 Jan;34(1):101383. doi: 10.1016/j.beem.2020.101383. Epub 2020 Jan 31.
9
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.胰岛素样生长因子-I受体与甲状腺相关性眼病
Endocr Rev. 2019 Feb 1;40(1):236-267. doi: 10.1210/er.2018-00066.
10
Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.格雷夫斯眼病患者眼眶成纤维细胞中结缔组织生长因子(CTGF)表达的改变
PLoS One. 2015 Nov 24;10(11):e0143514. doi: 10.1371/journal.pone.0143514. eCollection 2015.